Literature DB >> 8890185

IS10/Tn10 transposition efficiently accommodates diverse transposon end configurations.

R M Chalmers1, N Kleckner.   

Abstract

Transposon Tn10 and its component insertion sequence IS10 move by non-replicative transposition. We have studied the array of reaction intermediates and products in a high efficiency in vitro IS10/Tn10 transposition reaction. Synapsis of two transposon ends, followed by cleavage and strand transfer, can occur very efficiently irrespective of the relative locations and orientations of the two ends. The two participating ends can occur in inverted or direct orientation on the same molecule or, most importantly, on two different molecules. This behavior contrasts sharply with that of Mu, in which transposition is strongly biased in favor of inverted repeat synapsis. Mechanistically, the absence of discrimination amongst various end configurations implies that the architecture within the IS10/Tn10 synaptic complex is relatively simple, i.e. lacking any significant intertwining of component DNA strands. Biologically these observations are important because they suggest that the IS10 insertion sequence module has considerable flexibility in the types of DNA rearrangements that it can promote. Most importantly, it now seems highly probable that a single non-replicative IS10 element can promote DNA rearrangements usually attributed to replicative transposition, i.e. adjacent deletions and cointegrates, by utilizing transposon ends on two sister chromosomes. Other events which probably also contribute to the diversity of IS10/Tn10-promoted rearrangements are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890185      PMCID: PMC452251     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Excision of Tn10 from the donor site during transposition occurs by flush double-strand cleavages at the transposon termini.

Authors:  H W Benjamin; N Kleckner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Efficient Mu transposition requires interaction of transposase with a DNA sequence at the Mu operator: implications for regulation.

Authors:  M Mizuuchi; K Mizuuchi
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

3.  A specific class of IS10 transposase mutants are blocked for target site interactions and promote formation of an excised transposon fragment.

Authors:  D B Haniford; A R Chelouche; N Kleckner
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

4.  Cointegrate formation by IS50 requires multiple donor molecules.

Authors:  A Lichens-Park; M Syvanen
Journal:  Mol Gen Genet       Date:  1988-02

5.  Molecular model for the transposition and replication of bacteriophage Mu and other transposable elements.

Authors:  J A Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

Review 6.  The maize transposable element activator (Ac).

Authors:  R Kunze
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

7.  The three chemical steps of Tn10/IS10 transposition involve repeated utilization of a single active site.

Authors:  S Bolland; N Kleckner
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

8.  Induction of the SOS response by IS1 transposase.

Authors:  D Lane; J Cavaillé; M Chandler
Journal:  J Mol Biol       Date:  1994-09-30       Impact factor: 5.469

9.  Aberrant Transpositions of Maize Double Ds-Like Elements Usually Involve Ds Ends on Sister Chromatids.

Authors:  J. J. English; K. Harrison; JDG. Jones
Journal:  Plant Cell       Date:  1995-08       Impact factor: 11.277

10.  A symmetrical six-base-pair target site sequence determines Tn10 insertion specificity.

Authors:  S M Halling; N Kleckner
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

View more
  24 in total

1.  Protein-DNA contacts and conformational changes in the Tn10 transpososome during assembly and activation for cleavage.

Authors:  P Crellin; R Chalmers
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

2.  A target specificity switch in IS911 transposition: the role of the OrfA protein.

Authors:  C Loot; C Turlan; P Rousseau; B Ton-Hoang; M Chandler
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

3.  Nucleotide sequence and evolution of the five-plasmid complement of the phytopathogen Pseudomonas syringae pv. maculicola ES4326.

Authors:  John Stavrinides; David S Guttman
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

4.  Early intermediates of mariner transposition: catalysis without synapsis of the transposon ends suggests a novel architecture of the synaptic complex.

Authors:  Karen Lipkow; Nicolas Buisine; David J Lampe; Ronald Chalmers
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

5.  A simple topological filter in a eukaryotic transposon as a mechanism to suppress genome instability.

Authors:  Corentin Claeys Bouuaert; Danxu Liu; Ronald Chalmers
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

6.  Mutations and rearrangements in the genome of Sulfolobus solfataricus P2.

Authors:  Peter Redder; Roger A Garrett
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

7.  The human SETMAR protein preserves most of the activities of the ancestral Hsmar1 transposase.

Authors:  Danxu Liu; Julien Bischerour; Azeem Siddique; Nicolas Buisine; Yves Bigot; Ronald Chalmers
Journal:  Mol Cell Biol       Date:  2006-11-27       Impact factor: 4.272

Review 8.  Gene therapy vectors: the prospects and potentials of the cut-and-paste transposons.

Authors:  Corentin Claeys Bouuaert; Ronald M Chalmers
Journal:  Genetica       Date:  2009-08-02       Impact factor: 1.082

Review 9.  Insertion sequences.

Authors:  J Mahillon; M Chandler
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

10.  Efficient transposition of IS911 circles in vitro.

Authors:  B Ton-Hoang; P Polard; M Chandler
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.